E2F1 and colorectal carcinoma: Dysregulation of E2F family (E2F1, E2F3 and E2F4) expression activates or silences oncogenes or tumor suppressors at multiple levels of gene regulation and is involved in CRC progression (Kent and Leone, 2019; Xu et al., 2021).